J. Mendes

Multiple Myeloma in Portugal: Burden of Disease and Cost of Illness

C. Geraldes, F. Trigo, M. Neves, 2021, PharmacoEconomics.

Indirect Treatment Comparison of Daratumumab, Pomalidomide, and Dexamethasone Versus Standard of Care in Patients with Difficult-to-Treat Relapsed/Refractory Multiple Myeloma

B. Heeg, A. Lam, Jianming He, 2022, Advances in Therapy.

A data-driven model for COVID-19 pandemic – Evolution of the attack rate and prognosis for Brazil

M. Moret, F. Scorza, C. Chow, 2021, Chaos, Solitons & Fractals.

Treatment Regimens for Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: A Systematic Literature Review and Network Meta-analysis

M. Dimopoulos, Shaji K. Kumar, T. Facon, 2022, Advances in Therapy.